News 2019
Medigus Sold Micro Cameras to Two Leading Defense Organizations
The company is engaged in advanced negotiations with several defense organizations for new R&D defense projects
Medigus Announced Commercial Sale of the ScoutCam Micro Video Cameras to a Global Nuclear Reactors Group
Medigus Receives First Substantial Commercial Order for its Integrated Visualization Device
The company completed additional milestone in the agreement with A.M. Surgical, Inc. The agreed payment for the milestone is $650,000
Medigus to Invest $5 Million in Algomizer Group
The Investment is Part of the Company’s Strategy to Enhance the Company and Create Shareholders’ Value, the Company will Hold 17.9% at Algomizer Group
Medigus Reports $1.1 Million Order Backlog for Its Micro-Camera Business
Medigus Signs a Licensing and Sale Agreement for the MUSE™ in Greater China for $3 Million The company is acting to further commercialize and engage in additional similar MUSE™ licensing and sale agreements in additional territories
The company is acting to further commercialize and engage in additional similar MUSE™ licensing and sale agreements in additional territories
Medigus Received European Patent Notice Allowance for ScoutCam Irrigation System Technology
Medigus Completes patient enrolment of its First Multi-Center MUSE™ Clinical Study in China as Part of the CFDA Clearance Process
Medigus Announces the Appointment of Liron Carmel as Chief Executive Officer
Medigus Files Annual Report on Form 20-F for the Year Ended December 31, 2018
Medigus to Establish with Linkury an E-Commerce Platform for CBD Products
The Platform will Utilize Advanced Advertisement Technologies Developed by Linkury
Medigus Announces Preliminary Interest in the CBD and Medical Cannabis Industry
Medigus Announces US Patent for Micro ScoutCam™ Micro-Visual Technology
Medigus Announces US Patent for Micro ScoutCam™ Micro-Visual Technology (2)
Medigus to Participate in a European Consortium for the Development of a Fluorescent Colonoscope Intended to Improve Detection of Colorectal Cancer
Medigus Announces CEO Chris Rowland to Step Down
